查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1179904

听诊器全球市场 2023-2030

Global Stethoscope Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内（2023-2030 年），听诊器的全球市场规模预计将以 5.6% 的复合年增长率增长。

听诊器可以放大身体内部的声音，例如心音、肺音和碗音。 所有内臟声音都有一个“标准”频段，医生在检查患者时会听到这些频段。

市场动态

不断增长的老年人口和相关的慢性病推动了全球听诊器市场的增长。

全球老年人口和与年龄相关的慢性病不断增加将推动市场增长。

根据国家老龄化委员会的数据，65 岁以上的成年人中约有 80% 至少患有一种疾病，68% 患有两种或两种以上疾病。 老年人的常见疾病包括慢性阻塞性肺疾病（COPD）、心力衰竭、慢性肾脏病（CKD）、缺血性心脏病（或冠状动脉疾病）和高血压（高血压）。 在预测期内，不断增长的老年人口和相关的慢性病推动了全球听诊器市场的增长。 例如 例如，根据美国经济和社会事务局的数据，2020年65岁及以上的人口将达到约7.27亿，预计到2050年将达到15亿。 到 2050 年，全球 65 岁及以上人口的比例预计将达到 16%。 根据美国国立卫生研究院的数据，到 2030 年，85 岁及以上的人口将激增。

此外，根据美国肺臟协会的数据，2020 年将有 1250 万人（占成年人的 5.0%）被诊断患有 COPD（慢性阻塞性肺病、慢性支气管炎、肺气肿）。 与较年轻的年龄组相比，65 岁及以上人群的比例更高。 根据美国心臟协会 2022 年心脏病和中风统计更新情况说明书，CVD 将在 2020 年导致全球约 1905 万人死亡。 因此，上述数据表明，在预测期内，老年人口和相关慢性病的增加将推动全球听诊器市场的增长。

高成本和缺乏熟练医务人员阻碍了全球听诊器市场的增长。

然而，一些变体的高成本和熟练的医疗保健专业人员的短缺将成为市场的製约因素。 一些最先进的变体对于一些医疗保健专业人员来说太贵了，无法负担。 同样，缺乏专业的医疗保健提供者和对高端产品的了解不足可能会阻碍该行业的发展。

COVID-19 影响分析

COVID-19 的流行增加了对医疗保健援助的需求，并且由于 COVID-19 是一种呼吸系统疾病，因此在治疗环境中扩大对肺部和心臟的关注至关重要。 在这种特殊情况下，现有的治疗方法会出现各种困难的结果，因此这里也正在寻求基于技术的医疗保健解决方案。 在世界科技繁荣时期，无线听诊器对于治疗这种罕见疾病至关重要，并且可以将感染风险降到最低。 因此，对医疗保健援助的日益增长的需求和由流行病驱动的听诊器创新正在对全球市场产生积极影响。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 老年人口增加
      • 创新与发展
    • 约束因素
      • 医疗保健专业人员成本高且短缺
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 电子产品
  • 声学

第 8 章的设计

  • 单头
  • 双头
  • 三重头

第 9 章最终用户

  • 医院和诊所
  • 医疗机构
  • 门诊手术中心 (ASC)
  • 家庭医疗机构
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 产品基准
  • 主要发展和战略

第12章公司简介

  • 3M
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Welch Allyn
  • American Diagnostic Corporation
  • EKuore
  • Dongjin Medical Co. Ltd
  • Cardionics
  • Eko Devices
  • Medline Industries Inc.
  • Smiths Medical
  • GF Health Products Inc.

第13章 DataM

简介目录
Product Code: DMMD1261

Market Overview

The global stethoscope market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 5.6% during the forecast period (2023-2030).

The stethoscope allows the amplification of internal body sounds from the heart, lungs, and bowls. Every internal organ sound has a "standard" frequency range that doctors listen to during patient checkups.

Market Dynamics

The rising geriatric population and related chronic diseases promote the global stethoscope market growth.

The growing geriatric population and age-related chronic diseases worldwide will fuel the market growth.

According to the National Council on Aging, Inc., around 80% of adults 65 and older have at least one condition, while 68% have two or more. A few of the most common conditions among older adults are Chronic obstructive pulmonary disease (COPD), Heart failure, chronic kidney disease (CKD), Ischemic heart disease (or coronary heart disease), Hypertension (high blood pressure), and others. The growing geriatric population and related chronic cases fuel the global stethoscope market growth during the forecast period. For instance, according to the United States Department of Economics and Social Affairs, about 727 million people aged 65 and over in 2020 are estimated to reach 1.5 billion by 2050. share of the population 65 and above globally is expected to be 16% by 2050. According to NIH, by 2030, the population of people aged 85 and over will rise rapidly.

Moreover, according to the American Lung Association, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema. Rates were higher among those 65 and older compared to younger age groups. According to the 2022 heart disease and Stroke Statistics Update Fact Sheet from American Heart Association, Inc., CVD accounted for approximately 19.05 million global deaths in 2020. Thus, the above data indicate that the growing geriatric population and related chronic diseases will drive the growth of the worldwide stethoscope market during the forecasted period.

The high cost and dearth of skilled healthcare professionals will hamper the global Stethoscope market growth.

However, the high cost of some variants and the dearth of skilled healthcare professionals will be a market-restraining aspect. Some of the cutting-edge technology variants are costly, and a few healthcare professionals cannot afford them. Likewise, the shortage of professional healthcare providers and inadequate understanding of high-end products will hinder the industry's growth.

COVID-19 Impact Analysis

Because of the COVID-19 pandemic, the need for healthcare assistance is raised and since COVID-19 is a respiratory disease, expanding attention to the lungs and heart in therapeutic circumstances is vital. Again, tech-enabled healthcare answers are being pursued when this unique situation leads to different outcomes that are challenging to treat with existent practices. Wireless stethoscopes are essential to the worldwide technology boom for treating this unusual disease with minimal risk of transmission. Therefore, the increased need for healthcare assistance and pandemic-driven innovations in stethoscopes has positively impacted the global market.

Segment Analysis

The electronic stethoscope is predicted to grow at the fastest CAGR during the forecast period (2022-2029)

An electronic stethoscope electronically amplifies body sounds. Since the sound signals are transmitted electronically, they can be wireless, provide noise reduction and interfaced with computers, thereby can be further investigated and stored for future usefulness. Electronic stethoscopes are anticipated to boost at a high CAGR during the projection years owing to the new product developments and introductions into the market. According to For instance, in August 2021, Eko Devices, Inc. launched its DUO ECG + Digital Stethoscope. This two-in-one electronic stethoscope tracks electrical activity and can be integrated with hospital electronic health records. Similarly, in 2020, Thinklabs One introduced Safe Distance AuscultationTM, a technologically sophisticated digital stethoscope that allows healthcare experts to be safe during COVID-19. Likewise, in April 2020, Polish telemedicine innovations company StethoMe launched its artificial intelligence wireless stethoscope after its current collaborations with MaQuestionMedicale and HomeDoctor, prominent European telemedicine providers.

Similarly, in April 2022, the Centre for Development of Advanced Computing (C-DAC) based in Mohali designed a wireless electronic stethoscope that allows doctors from remote locations to diagnose patients' heartbeats. Again, in April 2022, Israeli startup Sanolla Ltd. received the United States Food and Drug Administration 510(k) clearance for its smart-infrasound stethoscope Vox. Thus, the abovementioned data indicates that the increasing product developments and introductions contribute to the growth of the electronic stethoscope segment in the forecasted period.

Geographical Analysis

The North American region dominates the global Stethoscope market.

The initiatives by various government and non-government organizations to raise awareness & understanding of cardiac and pulmonary diseases are fueling the North American stethoscope market growth at a high CAGR. For example, a national initiative called "Million Hearts 2022" is being followed to avert 1 million heart attacks within five years. It is a joint endeavor of the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services. Likewise, the National Heart, Lung, and Blood Institute has started a national campaign: Learn More, Breathe Better, to expand awareness & understanding of COPD and its risk factors. Additionally, this campaign supports earlier detection and treatment in slowing the disease and enhancing the quality of life.

Furthermore, different market developments in this region also contribute to the North American stethoscope market growth. For instance, in November 2021, eMurmur, a global healthcare technology partner, released the world's first open software platform for advanced digital auscultation (stethoscope technology), presently available in the United States. Similarly, in April 2022, Sanolla introduced the AI-ready VoqX infrasound stethoscope for clinical use in the United States. Again, in June 2021, HD Medical made its flagship product, HD Steth, available online through Stethoscope.com, one of the leading online stethoscope and medical product distributors in the United States.

Additionally, the growing number of hospital visits in North America ensures the hold of North America over the global stethoscope market. According to the CDC, about 83.4% of adults visited a healthcare professional in the U.S. in 2020. The number of visits in the U.S. was 860.4 million, and the percentage of visits made to primary care physicians was 51.2%. Therefore, the above data indicate that North America will dominate the global stethoscope market throughout the forecast period.

Competitive Landscape

The Stethoscope market is moderately competitive due to the presence of key local and global players. Some key players are Welch Allyn, 3M, American Diagnostic Corporation, EKuore, Dongjin Medical Co. Ltd, Cardionics, Eko Devices, Medline Industries Inc., Smiths Medical and GF Health Products Inc. The key players keep the majority of their market share to themselves through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in October 2020, 3M and Eko formed a partnership to combine 3M's Littmann stethoscope with Eko's digital innovations.

3M

Overview:

3M is a leading manufacturer all over the world. It has a global presence and is headquartered in Saint Paul, Minnesota, the United States, which was founded on June 13, 1902. 3M deals with 60,000 various products under many brands; the product categories are adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films.

Product Portfolio:

The 3M product portfolio of Stethoscope has 3M Littmann CORE Digital Stethoscope: The 3M Littmann CORE Digital Stethoscope delivers up to 40x amplification (at peak frequency versus analog mode), active noise cancellation, in-app sound wave visualization and other powerful features developed to give a clearer picture of patient health.

The global stethoscope market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Geriatric Population
      • 4.1.1.2. Innovations And Developments
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Lack of Healthcare Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Electronic
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Acoustic

8. By Design

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 8.1.2. Market Attractiveness Index, By Design
  • 8.2. Single Head
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Double Head
  • 8.4. Triple Head

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals And Clinics
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Healthcare Institutions
  • 9.4. Ambulatory surgical centers (ASCs)
  • 9.5. Home care Settings
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Key Developments and Strategies

12. Company Profiles

  • 12.1. 3M
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Welch Allyn
  • 12.3. American Diagnostic Corporation
  • 12.4. EKuore
  • 12.5. Dongjin Medical Co. Ltd
  • 12.6. Cardionics
  • 12.7. Eko Devices
  • 12.8. Medline Industries Inc.
  • 12.9. Smiths Medical
  • 12.10. GF Health Products Inc.

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us